Industry-backed trials are positive

Share this article:
An analysis of studies registered on ClinicalTrials.gov showed those funded by industry were more apt to show positive outcomes but less apt to be published shortly after completion than trials funded by other sources.

Out of 546 trials, noted researchers writing in Annals of Internal Medicine, industry-funded trials reported positive outcomes in 85% of publications vs. 50% for government-funded trials, and 72% for nonprofits or non-federal organization-funded trials. The rate of publication within two years of study completion ranged from 32% among industry-funded trials to 56% among nonprofit or nonfederal organization–funded trials without industry contributions.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Headliner: Ipsen head leads continental charge

Headliner: Ipsen head leads continental charge

"When I look at the business, I actually see patients in my mind. I don't see numbers."

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets